Brief: Rubius Therapeutics Reports Q2 Results

Rubius Therapeutics

09/08/2021 14:21

Aug 9 (Reuters) - Rubius Therapeutics Inc  RUBY.O :
    * Q2 LOSS PER SHARE $0.56
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.49 -- REFINITIV IBES
DATA
    * AS OF JUNE 30, 2021, CASH, CASH EQUIVALENTS AND
INVESTMENTS WERE
$298.2 MILLION

Source text for Eikon:  ID:nGNX3Zslcj 
Further company coverage:  RUBY.O 

 ((Reuters.Briefs@thomsonreuters.com;))